2024 Avoca Quality Consortium Summit

Speakers & Panelists


Corey Alexander, MBA
Global Head, GCP Inspections and Process Quality, RDQ CQA
Novartis


Lauri Befus
Vice President of Operations
M3 Wake Research


Trevor Cole, BHS, MBA-HCM-PM, CCRC, PMP, RN
Director
Avoca, A WCG Company


Dominic De Bellis, PhD
Executive Director, Artificial Intelligence Strategy & Operations Lead, Medical Writing & Disclosure | Global Clinical Trial Operations
Merck


Katie Delaney, DHA, MBA
Subject Matter Expert, AQC
Avoca, A WCG Company


Katie Doble
Vice President
IQ Clarity


Keith Dorricott
Senior Consultant
Avoca Quality Consortium


Rachel Dossman
Director, Clinical Process Compliance, Clinical Development Operations
AbbVie


Dawn East
Associate Vice President – Global Medicine Quality
Eli Lilly and Company


Aramy R. Forrest
Sr. Director Project Management and Clinical Affairs, Development Innovations
Sarah Cannon Research Institute


David Fryrear, MS
Chief Quality Officer
Astellas


Karen Harvey
Senior Director, Avoca Quality Consortium
Avoca, A WCG Company


Jill Johnston, CCRA, CPM
Chief Innovation Officer
WCG


Gaurav Josan
Senior Vice President, Research & Development
Clario


Mitchell Katz, PhD
Senior Vice President, Global Clinical Operations
Kyowa Kirin


Saubiya Kidwai
Vice President
PPD/Thermo Fisher


Caryn Laermer
Head, Member Engagement
Avoca, A WCG Company


Irene Michas, PhD, MSc
Senior Consultant
Avoca, A WCG Company


Kevin Richards
Head of Quality Investigations and Analytics
AstraZeneca


Carly Santer, PhD
Strategic Initiatives Project Leader & Sustainability Activator
Bayer


Jennifer Sheller
Senior Vice President, Head of Global Clinical Trial Operations
Merck


Jean Sposaro
Director, Global Clinical Trial Industry Collaborations, Global Drug Development Operations
Bristol Myers Squibb


Sam Srivastava
CEO
WCG


Paula Walker
Global Head of Risk Based Quality Management
Roche


Michelle Webb
Vice President, Avoca Quality Consortium
Avoca, A WCG Company

More speakers to be announced